We used the Nanostring immunology panel to measure the expression of 568 immune-related genes from peripheral blood derived CD4+ T cells and CD14+ monocytes from a subset of 18 MS patients and 18 controls subjects. Here, CD14 is linked to myeloid sarcoma.